Apple Tree Partners
Apple Tree Partners, founded in 1999, is a life sciences investment firm with $2.9 billion in committed capital and offices in New York, South San Francisco, and Cambridge, MA.
Company History
Apple Tree Partners was founded in 1999. Since its inception, the company has focused on investing in life sciences companies across various stages of their development cycles. With over two decades of experience and growth, Apple Tree Partners has established itself as a significant player in the biotechnology investment sector.
Investment Capital
Apple Tree Partners manages $2.9 billion in committed capital. This significant financial resource allows the company to invest in a wide array of life sciences companies from their seed stages through IPO and beyond. The company's substantial capital base facilitates its ability to support transformative biotechnology ventures over the long term.
Office Locations
Apple Tree Partners operates offices in three major locations: New York, South San Francisco, and Cambridge, MA. These strategic locations enable the company to maintain a robust presence in key hubs of biotechnology innovation and investment within the United States.
ATP R&D Labs
ATP R&D Labs, located in New Haven, Connecticut, serves as Apple Tree Partners' in-house incubator and accelerator. The lab provides a range of services, including compound screening, cellular and molecular assays, data analytics, and preclinical pharmacology. These services support the development of innovative life sciences companies that are part of Apple Tree Partners' portfolio.
Focus Areas in Biotechnology
Apple Tree Partners focuses on creating and investing in transformative biotechnology companies. The firm engages in the development of science-based companies, from pre-IP concepts to spinouts from existing company pipelines. This approach enables Apple Tree Partners to support groundbreaking ideas and technologies that have the potential to advance the life sciences field.